Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HALI L LIRETTE

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1326531583
CMS profile
10838025
Location
LAFAYETTE, LA

General Payments · PY2021–2024

$2,280.23

  • Reported across 102 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$598.44

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $598.44 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Axsome Therapeutics, Inc. $124.99 1
ABBVIE INC. $109.37 1
ITI, Inc. $102.76 1
Vanda Pharmaceuticals Inc. $60.51 2
Ardelyx, Inc. $38.89 2
Otsuka America Pharmaceutical, Inc. $38.05 2
Gilead Sciences, Inc. $30.56 1
Insulet Corporation $24.86 1
PFIZER INC. $24.72 1
Endo Pharmaceuticals Inc. $22.90 1
Lilly USA, LLC $20.83 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $329.78 19
PY2022 $668.07 32
PY2023 $683.94 37
PY2024 $598.44 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $109.37 10/01/2024 Food and Beverage Undisputed 01/23/2026 1107544242 CMS
Ardelyx, Inc. $20.29 10/10/2024 Food and Beverage Undisputed 01/23/2026 1146735084 CMS
Ardelyx, Inc. $18.60 12/12/2024 Food and Beverage Undisputed 01/23/2026 1146735086 CMS
Axsome Therapeutics, Inc. $124.99 10/23/2024 Food and Beverage Undisputed 01/23/2026 1148361566 CMS
Endo Pharmaceuticals Inc. $22.90 02/28/2024 Food and Beverage Undisputed 01/23/2026 1137020356 CMS
Gilead Sciences, Inc. $30.56 08/05/2024 Food and Beverage Undisputed 01/23/2026 1133719849 CMS
Insulet Corporation $24.86 11/19/2024 Food and Beverage Undisputed 01/23/2026 1116823358 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.76 10/24/2024 Food and Beverage Undisputed 01/23/2026 1143534716 CMS
Lilly USA, LLC $20.83 05/01/2024 Food and Beverage Undisputed 01/23/2026 1135640012 CMS
Otsuka America Pharmaceutical, Inc. $20.16 10/21/2024 Food and Beverage Undisputed 01/23/2026 1119123416 CMS
Otsuka America Pharmaceutical, Inc. $17.89 11/18/2024 Food and Beverage Undisputed 01/23/2026 1119123418 CMS
PFIZER INC. $24.72 08/29/2024 Food and Beverage Undisputed 01/23/2026 1131953120 CMS
Vanda Pharmaceuticals Inc. $30.54 09/18/2024 Food and Beverage Undisputed 01/23/2026 1133954536 CMS
Vanda Pharmaceuticals Inc. $29.97 11/06/2024 Food and Beverage Undisputed 01/23/2026 1133954538 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.